Haberlen Sabina A, Nakigozi Gertrude, Gray Ronald H, Brahmbhatt Heena, Ssekasanvu Joseph, Serwadda David, Nalugoda Fred, Kagaayi Joseph, Wawer Maria J
*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Rakai Health Sciences Program, Entebbe, Uganda; and ‡Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):241-7. doi: 10.1097/QAI.0000000000000600.
A decade after the rollout of antiretroviral therapy (ART) in sub-Saharan Africa, the effects of this structural change on social aspects of HIV, such as rates of HIV disclosure to partners, remain largely unmeasured. We evaluated whether the introduction of ART was associated with disclosure of HIV diagnosis to spouses in Rakai, Uganda, using longitudinal, population-based data.
We identified individuals in marital/cohabitating unions who were newly diagnosed with HIV in Rakai Community Cohort Study surveys between 2000 and 2008, where ART was introduced in mid-2004. Using discrete-time survival analysis, we assessed the hazard of self-reported HIV disclosure to spouse after diagnosis pre-ART and post-ART rollout, adjusting for individual and union characteristics. Disclosure in the ART period was further stratified by ART initiation.
The analysis included 557 married adults, 264 of whom were diagnosed with HIV before ART was available (2000-2004), and 293 diagnosed after ART was introduced (2005-2008). The cumulative incidence of self-reported disclosure was 75.2% in the post-ART period, compared with 58.3% before ART availability [P < 0.001, adjusted hazard ratio: 1.46 (95% confidence interval: 1.16 to 1.83)]. In the post-ART period, observed disclosure rates were 39% (72 of 184) among those not in HIV care, 65% (82 of 126) among those in pre-ART care, and 85% (64 of 75) among persons on ART (P < 0.001).
Treatment availability and use, especially ART initiation, was associated with increased self-disclosure of HIV diagnosis to partners. ART access may facilitate the prevention of transmission to uninfected partners and linkage to treatment for infected couples.
在撒哈拉以南非洲地区推行抗逆转录病毒疗法(ART)十年后,这一结构性变化对艾滋病毒社会层面的影响,如向伴侣披露艾滋病毒感染情况的比例,在很大程度上仍未得到衡量。我们利用基于人群的纵向数据,评估了乌干达拉凯地区推行ART是否与向配偶披露艾滋病毒诊断情况有关。
我们在拉凯社区队列研究2000年至2008年的调查中,确定了婚姻/同居关系中首次被诊断出感染艾滋病毒的个体,ART于2004年年中在该地区推行。使用离散时间生存分析,我们评估了在ART推行前和推行后诊断出感染艾滋病毒后自我报告向配偶披露感染情况的风险,并对个体和伴侣特征进行了调整。在ART时期的披露情况进一步按开始接受ART治疗进行分层。
分析纳入了557名已婚成年人,其中264人在有ART可用之前(2000年至2004年)被诊断出感染艾滋病毒,293人在ART推行后(2005年至2008年)被诊断出感染艾滋病毒。ART推行后自我报告披露的累积发生率为75.2%,而在有ART可用之前为58.3%[P<0.001,调整后的风险比:1.46(95%置信区间:1.16至1.83)]。在ART推行后,未接受艾滋病毒治疗的人群中观察到的披露率为39%(184人中的72人),接受ART治疗前的人群中为65%(126人中的82人),接受ART治疗的人群中为85%(75人中的64人)(P<0.001)。
治疗的可及性和使用,尤其是开始接受ART治疗,与向伴侣自我披露艾滋病毒诊断情况的增加有关。获得ART治疗可能有助于预防向未感染伴侣传播艾滋病毒,并使感染艾滋病毒的夫妇获得治疗。